Cambridge Nutritional Sciences plc (LON:CNSL – Get Free Report) insider Carolyn Rand bought 100,000 shares of the company’s stock in a transaction on Tuesday, November 18th. The shares were acquired at an average price of GBX 2 per share, with a total value of £2,000.
Carolyn Rand also recently made the following trade(s):
- On Tuesday, November 18th, Carolyn Rand purchased 50,000 shares of Cambridge Nutritional Sciences stock. The shares were acquired at an average cost of GBX 2 per share, with a total value of £1,000.
Cambridge Nutritional Sciences Stock Up 11.1%
CNSL stock opened at GBX 2.50 on Wednesday. Cambridge Nutritional Sciences plc has a twelve month low of GBX 1.86 and a twelve month high of GBX 4.38. The firm has a market cap of £5.95 million, a price-to-earnings ratio of 3.57 and a beta of 3.89. The business’s fifty day simple moving average is GBX 2.73 and its two-hundred day simple moving average is GBX 3.08.
Cambridge Nutritional Sciences Company Profile
Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition.
Further Reading
- Five stocks we like better than Cambridge Nutritional Sciences
- Upcoming IPO Stock Lockup Period, Explained
- Buyer Beware: Carvana Is Driving an Auto Lending Crisis
- What is a buyback in stocks? A comprehensive guide for investors
- Healthcare Rotation Underway: 3 Stocks Leading the Charge
- What is the Shanghai Stock Exchange Composite Index?
- Medtronic Stock Finds Its Footing—Now It’s Gaining Momentum
Receive News & Ratings for Cambridge Nutritional Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Nutritional Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
